HealthGLP-1 weight-loss drugs boom nudges cannabis dispensaries to rethink offerings
- 21-Apr-2026
The surging popularity of GLP-1 weight-loss drugs is quietly reshaping the $40 billion U.S. cannabis market, experts and industry executives said, as retailers adjust product offerings to suit changing consumer behavior tied to the therapies. Users on online forums reported diminished cravings and uncertainty about how GLP-1 therapies might influence marijuana’s aftereffects – particularly appetite-driven […]
